Cargando…
Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China
It is critical to determine the real-world performance of vaccines against coronavirus disease 2019 (COVID-19) so that appropriate treatments and policies can be implemented. There was a rapid wave of infections by the Omicron variant in Jilin Province (China) during spring 2022. We examined the eff...
Autores principales: | Xu, Hongqin, Li, Hongyan, You, Hailong, Zhang, Peng, Li, Nan, Jiang, Nan, Cao, Yang, Qin, Ling, Qin, Guixiang, Qu, Hongbo, Wang, Heyuan, Zou, Bo, He, Xia, Li, Dan, Zhao, Huazhong, Huang, Gang, Li, Yang, Zhang, Hefeng, Zhu, Liping, Qiao, Hongmei, Li, Hongjun, Liu, Shurong, Gu, Lina, Yin, Guidong, Hu, Ye, Xu, Songbai, Guo, Weiying, Wang, Nanya, Liu, Chaoying, Gao, Pujun, Cao, Jie, Zheng, Yang, Zhang, Kaiyu, Wang, Yang, Chen, Hui, Zhang, Jian, Mu, Dongmei, Niu, Junqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817129/ https://www.ncbi.nlm.nih.gov/pubmed/36398721 http://dx.doi.org/10.1080/22221751.2022.2149935 |
Ejemplares similares
-
Association of Nirmatrelvir/Ritonavir Treatment on Upper Respiratory Severe Acute Respiratory Syndrome Coronavirus 2 Reverse Transcription-Polymerase Chain Reaction (SARS-Cov-2 RT-PCR) Negative Conversion Rates Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19)
por: Li, Hongyan, et al.
Publicado: (2022) -
A 1-year longitudinal study on COVID-19 convalescents reveals persistence of anti-SARS-CoV-2 humoral and cellular immunity
por: Li, Yang, et al.
Publicado: (2022) -
Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2.2 in China: A case–control study
por: Zhang, Xiaqing, et al.
Publicado: (2023) -
RT-LAMP assay for rapid detection of the R203M mutation in SARS-CoV-2 Delta variant
por: Yang, Jianing, et al.
Publicado: (2022) -
The unreversible reduced but persistent activated NK and CD8(+) T cells in severe/critical COVID-19 during omicron pandemic in China
por: Qin, Ling, et al.
Publicado: (2023)